Despite some progress, the industry is still in a wait-and-see mode regarding the administration, Congress, and FDA.
Gil Roth
Advertisement
Gil Roth is president of the Pharma & Biopharma OutsourcingAssociation, gil.roth@pharma-bio.org.
Articles by Gil Roth
The outlook for the CMO and CDMO industry may be affected by ever-changing politics.
Advertisement
Latest Updated Articles
- Viewpoint: Challenges and Opportunities for CDMOs
Published: February 1st 2017 | Updated:
- CDMOs: New Administration, New Frontier
Published: August 1st 2017 | Updated:
Advertisement
Advertisement
